• Login
    View Item 
    •   MUT Research Archive
    • Journal Articles
    • School of Pure, Applied and Health Sciences (JA)
    • Journal Articles (PAS)
    • View Item
    •   MUT Research Archive
    • Journal Articles
    • School of Pure, Applied and Health Sciences (JA)
    • Journal Articles (PAS)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases

    Thumbnail
    View/Open
    Th17 Cells as Potential Probiotic Therapeutic Targets.pdf (739.4Kb)
    Date
    2015
    Author
    Owaga, E.
    Hsieh, R.
    Mugendi, Beatrice J.
    Masuku, S.
    Metadata
    Show full item record
    Abstract
    Inflammatory bowel diseases (IBD) are characterized by wasting and chronic intestinal inflammation triggered by various cytokine-mediated pathways. In recent years, it was shown that T helper 17 (Th17) cells are involved in the pathogenesis of IBD, which makes them an attractive therapeutic target. Th17 cells preferentially produce interleukin (IL)-17A–F as signature cytokines. The role of the interplay between host genetics and intestinal microbiota in the pathogenesis of IBD was demonstrated. Probiotics are live microorganisms that when orally ingested in adequate amounts, confer a health benefit to the host by modulating the enteric flora or by stimulating the local immune system. Several studies indicated the effectiveness of probiotics in preventing and treating IBD (ulcerative colitis, and Crohn’s disease). Furthermore, there is mounting evidence of probiotics selectively targeting the Th17 lineage in the prevention and management of inflammatory and autoimmune diseases such as IBD. This review highlights critical roles of Th17 cells in the pathogenesis of IBD and the rationale for using probiotics as a novel therapeutic approach for IBD through manipulation of Th17 cells. The potential molecular mechanisms by which probiotics modulate Th17 cells differentiation and production are also discussed.
    URI
    http://hdl.handle.net/123456789/2743
    https://www.ncbi.nlm.nih.gov/pubmed/26340622
    https://www.researchgate.net/publication/281554332_Th17_Cells_as_Potential_Probiotic_Therapeutic_Targets_in_Inflammatory_Bowel_Diseases
    Collections
    • Journal Articles (PAS) [273]

    MUT Library copyright © 2017-2024  MUT Library Website
    Contact Us | Send Feedback
     

     

    Browse

    All of Research ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    MUT Library copyright © 2017-2024  MUT Library Website
    Contact Us | Send Feedback